Alice R Pressman

Summary

Affiliation: Kaiser Permanente
Country: USA

Publications

  1. pmc Should we reconsider the routine use of placebo controls in clinical research?
    Andrew L Avins
    Northern California Kaiser Permanente Division of Research, 2000 Broadway, Oakland, CA 94612, USA
    Trials 13:44. 2012
  2. pmc Adherence to placebo and mortality in the Beta Blocker Evaluation of Survival Trial (BEST)
    Alice Pressman
    Division of Research, Kaiser Permanente Northern California Oakland, CA 94612, United States
    Contemp Clin Trials 33:492-8. 2012
  3. doi request reprint A comparison of two worlds: How does Bayes hold up to the status quo for the analysis of clinical trials?
    Alice R Pressman
    Kaiser Permanente Division of Research, Oakland, CA 94612, USA
    Contemp Clin Trials 32:561-8. 2011
  4. doi request reprint Methods for assessing fracture risk prediction models: experience with FRAX in a large integrated health care delivery system
    Alice R Pressman
    Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA
    J Clin Densitom 14:407-15. 2011
  5. pmc Placebo adherence and mortality in the Heart and Estrogen/Progestin Replacement Study
    Amy M Padula
    School of Public Health, University of California, Berkeley, CA, USA
    Am J Med 125:804-10. 2012
  6. ncbi request reprint Fracture risk tool validation in an integrated healthcare delivery system
    Joan C Lo
    Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612, USA
    Am J Manag Care 17:188-94. 2011
  7. ncbi request reprint High-dose corticosteroid exposure and osteoporosis intervention in adults
    Maggie Che
    Department of Medicine, Kaiser Permanente Medical Center, Vacaville, California 95688 9430, USA
    Ann Allergy Asthma Immunol 97:497-501. 2006
  8. ncbi request reprint Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome
    Joan C Lo
    Division of Research, Kaiser Permanente of Northern California, 2000 Broadway Street, 2nd Floor, Oakland, CA 94612 2304, USA
    J Clin Endocrinol Metab 91:1357-63. 2006
  9. doi request reprint Patterns of infliximab use among Crohn's disease patients in a community setting
    Alice R Pressman
    Division of Research, Kaiser Permanente Northern California, Oakland, California 94612, USA
    Inflamm Bowel Dis 14:1265-72. 2008
  10. ncbi request reprint Limb fractures in elderly men as indicators of subsequent fracture risk
    Bruce Ettinger
    Division of Research, Kaiser Permanente Medical Care Program, Oakland, Calif 94611, USA
    Arch Intern Med 163:2741-7. 2003

Collaborators

Detail Information

Publications10

  1. pmc Should we reconsider the routine use of placebo controls in clinical research?
    Andrew L Avins
    Northern California Kaiser Permanente Division of Research, 2000 Broadway, Oakland, CA 94612, USA
    Trials 13:44. 2012
    ..An unrecognized consequence of this preference is that clinicians are more limited in their ability to provide the benefits of the non-specific healing effects of placebos in clinical practice...
  2. pmc Adherence to placebo and mortality in the Beta Blocker Evaluation of Survival Trial (BEST)
    Alice Pressman
    Division of Research, Kaiser Permanente Northern California Oakland, CA 94612, United States
    Contemp Clin Trials 33:492-8. 2012
    ..We explored this phenomenon by reanalyzing data from the placebo arm of the Beta Blocker Evaluation of Survival Trial (BEST), a randomized, double-blind, placebo-controlled trial of bucindolol and mortality...
  3. doi request reprint A comparison of two worlds: How does Bayes hold up to the status quo for the analysis of clinical trials?
    Alice R Pressman
    Kaiser Permanente Division of Research, Oakland, CA 94612, USA
    Contemp Clin Trials 32:561-8. 2011
    ..There is a paucity of literature comparing Bayesian analytic techniques with traditional approaches for analyzing clinical trials using real trial data...
  4. doi request reprint Methods for assessing fracture risk prediction models: experience with FRAX in a large integrated health care delivery system
    Alice R Pressman
    Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA
    J Clin Densitom 14:407-15. 2011
    ..01). Two versions of this risk tool have similar AUROCs, but alternative assessments indicate that addition of BMD improves performance. Multiple methods should be used to evaluate risk tool performance with less reliance on AUROC alone...
  5. pmc Placebo adherence and mortality in the Heart and Estrogen/Progestin Replacement Study
    Amy M Padula
    School of Public Health, University of California, Berkeley, CA, USA
    Am J Med 125:804-10. 2012
    ..Secondary aims included assessment of the association between placebo adherence and cause-specific morbidity and mortality...
  6. ncbi request reprint Fracture risk tool validation in an integrated healthcare delivery system
    Joan C Lo
    Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612, USA
    Am J Manag Care 17:188-94. 2011
    ..To evaluate the utility of the Fracture Risk Calculator (FRC, Foundation for Osteoporosis Research and Education) for predicting 10-year hip fracture risk within a "real world" population...
  7. ncbi request reprint High-dose corticosteroid exposure and osteoporosis intervention in adults
    Maggie Che
    Department of Medicine, Kaiser Permanente Medical Center, Vacaville, California 95688 9430, USA
    Ann Allergy Asthma Immunol 97:497-501. 2006
    ..High-dose corticosteroid exposure is associated with increased risk of bone loss and osteoporotic fractures...
  8. ncbi request reprint Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome
    Joan C Lo
    Division of Research, Kaiser Permanente of Northern California, 2000 Broadway Street, 2nd Floor, Oakland, CA 94612 2304, USA
    J Clin Endocrinol Metab 91:1357-63. 2006
    ..Polycystic ovary syndrome (PCOS) is associated with menstrual and reproductive abnormalities, insulin resistance, and obesity...
  9. doi request reprint Patterns of infliximab use among Crohn's disease patients in a community setting
    Alice R Pressman
    Division of Research, Kaiser Permanente Northern California, Oakland, California 94612, USA
    Inflamm Bowel Dis 14:1265-72. 2008
    ..We sought to understand predictors of initiation and discontinuation of infliximab in the community-based setting of Kaiser Permanente, Northern California, which provides integrated care to its members...
  10. ncbi request reprint Limb fractures in elderly men as indicators of subsequent fracture risk
    Bruce Ettinger
    Division of Research, Kaiser Permanente Medical Care Program, Oakland, Calif 94611, USA
    Arch Intern Med 163:2741-7. 2003
    ..Whether limb fracture in elderly men predicts future fracture is unknown...